PCS-2023: 3E0Y Introduction, Pericardial Cavity

PCS-2023 > 3 > 3E > 3E0 > 3E0Y

3E0	Physiological Systems and Anatomical Regions, Introduction
	Info:	Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
3E0Y	Introduction, Pericardial Cavity
3E0Y3	Percutaneous
3E0Y30	Antineoplastic
3E0Y304	Introduction of Liquid Brachytherapy Radioisotope into Pericardial Cavity, Percutaneous Approach
3E0Y305	Introduction of Other Antineoplastic into Pericardial Cavity, Percutaneous Approach
3E0Y30M	Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Percutaneous Approach
3E0Y32	Anti-infective
3E0Y328	Introduction of Oxazolidinones into Pericardial Cavity, Percutaneous Approach
3E0Y329	Introduction of Other Anti-infective into Pericardial Cavity, Percutaneous Approach
3E0Y33	Anti-inflammatory
3E0Y33Z	Introduction of Anti-inflammatory into Pericardial Cavity, Percutaneous Approach
3E0Y36	Nutritional Substance
3E0Y36Z	Introduction of Nutritional Substance into Pericardial Cavity, Percutaneous Approach
3E0Y37	Electrolytic and Water Balance Substance
3E0Y37Z	Introduction of Electrolytic and Water Balance Substance into Pericardial Cavity, Percutaneous Approach
3E0Y3B	Anesthetic Agent
3E0Y3BZ	Introduction of Anesthetic Agent into Pericardial Cavity, Percutaneous Approach
3E0Y3H	Radioactive Substance
3E0Y3HZ	Introduction of Radioactive Substance into Pericardial Cavity, Percutaneous Approach
3E0Y3K	Other Diagnostic Substance
3E0Y3KZ	Introduction of Other Diagnostic Substance into Pericardial Cavity, Percutaneous Approach
3E0Y3N	Analgesics, Hypnotics, Sedatives
3E0Y3NZ	Introduction of Analgesics, Hypnotics, Sedatives into Pericardial Cavity, Percutaneous Approach
3E0Y3T	Destructive Agent
3E0Y3TZ	Introduction of Destructive Agent into Pericardial Cavity, Percutaneous Approach
3E0Y3G	Other Therapeutic Substance
3E0Y3GC	Introduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Approach
3E0Y3S	Gas
3E0Y3SF	Introduction of Other Gas into Pericardial Cavity, Percutaneous Approach
3E0Y4	Percutaneous Endoscopic
3E0Y4G	Other Therapeutic Substance
3E0Y4GC	Introduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Endoscopic Approach
3E0Y7	Via Natural or Artificial Opening
3E0Y70	Antineoplastic
3E0Y704	Introduction of Liquid Brachytherapy Radioisotope into Pericardial Cavity, Via Natural or Artificial Opening
3E0Y705	Introduction of Other Antineoplastic into Pericardial Cavity, Via Natural or Artificial Opening
3E0Y70M	Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Via Natural or Artificial Opening
3E0Y7S	Gas
3E0Y7SF	Introduction of Other Gas into Pericardial Cavity, Via Natural or Artificial Opening

and

Physiological Systems and Anatomical Regions, Introduction

Introduction, Pericardial Cavity